Skip to main content

Articles

Page 212 of 343

  1. MicroRNAs are small non-coding RNAs that have been implicated in tumor initiation and progression. In a previous study we identified 138 miRNAs as differentially expressed in endometrial adenocarcinoma compare...

    Authors: Sanja Jurcevic, Karin Klinga-Levan, Björn Olsson and Katarina Ejeskär
    Citation: BMC Cancer 2016 16:261
  2. Brain metastases (BM) from colorectal cancer (CRC) are a rare event. However, the implications for affected patients are severe, and the incidence has been reported to be increasing. For clinicians, knowledge ...

    Authors: Troels Dreier Christensen, Karen-Lise Garm Spindler, Jesper Andreas Palshof and Dorte Lisbet Nielsen
    Citation: BMC Cancer 2016 16:260
  3. The non-canonical Wnt/Planar cell polarity (PCP) signaling pathway is a major player in cell migration during embryonal development and has recently been implicated in tumorigenesis.

    Authors: Cecilia Dyberg, Panagiotis Papachristou, Bjørn Helge Haug, Hugo Lagercrantz, Per Kogner, Thomas Ringstedt, Malin Wickström and John Inge Johnsen
    Citation: BMC Cancer 2016 16:259
  4. The information surgeons impart to patients and information patients want about surgery for cancer is important but rarely examined. This study explored information provided by surgeons and patient preferences...

    Authors: Angus G. K. McNair, F MacKichan, J. L. Donovan, S. T. Brookes, K. N. L. Avery, S. M. Griffin, T. Crosby and J. M. Blazeby
    Citation: BMC Cancer 2016 16:258
  5. Nurr1, a member of the orphan receptor family, plays an important role in several types of cancer. Our previous work demonstrated that increased expression of Nurr1 plays a significant role in the initiation a...

    Authors: Jian Wang, Zhi-Hong Yang, Hua Chen, Hua-Hui Li, Li-Yong Chen, Zhu Zhu, Ying Zou, Cong-Cong Ding, Jing Yang and Zhi-Wei He
    Citation: BMC Cancer 2016 16:257
  6. Endocrine resistance is a major obstacle to optimal treatment effect in breast cancer. Some genetic markers have been proposed to predict response to aromatase inhibitors (AIs) but the data is insufficient. Th...

    Authors: Maria Simonsson, Srinivas Veerla, Andrea Markkula, Carsten Rose, Christian Ingvar and Helena Jernström
    Citation: BMC Cancer 2016 16:256
  7. Comorbidity at the time of diagnosis is an independent prognostic factor for survival among women suffering from cervical or breast cancer. Although cancer screening practices have proven their efficacy for mo...

    Authors: Panayotis Constantinou, Rosemary Dray-Spira and Gwenn Menvielle
    Citation: BMC Cancer 2016 16:255
  8. Axitinib is a potent inhibitor of the vascular endothelial growth factor (VEGF) receptor family with clinical activity in patients with metastatic renal cell carcinoma (mRCC). Given this biochemical potency, t...

    Authors: Namita Chittoria, Housam Haddad, Paul Elson, Nizar M. Tannir, Laura S. Wood, Robert Dreicer, Jorge A. Garcia, Brian I. Rini and Eric Jonasch
    Citation: BMC Cancer 2016 16:254
  9. Osteosarcoma (OS) is well-known for poor prognosis due to its high incidence of proliferation and metastasis. Researches have provided valuable insights into the tumorigenesis of S100A9 in some cancers. We aim...

    Authors: Si Cheng, Xi Zhang, Ning Huang, Quanhe Qiu, Ying Jin and Dianming Jiang
    Citation: BMC Cancer 2016 16:253
  10. MicroRNAs have been shown to be important regulators of the immune response and the development of the immune system. It was reported that microRNA-125b (miR-125b) was down-regulated in macrophages challenged ...

    Authors: Zhenbiao Xu, Lianmei Zhao, Xin Yang, Sisi Ma, Yehua Ge, Yanxin Liu, Shilian Liu, Juan Shi and Dexian Zheng
    Citation: BMC Cancer 2016 16:252
  11. Luteinizing hormone-releasing hormone receptor (LHRHr) represents a promising therapeutic target for treating sex hormone-dependent tumors. We coupled cecropin B, an antimicrobial peptide, to LHRH’, a form of ...

    Authors: Xiaoyong Li, Bo Shen, Qi Chen, Xiaohui Zhang, Yiqing Ye, Fengmei Wang and Xinmei Zhang
    Citation: BMC Cancer 2016 16:251
  12. The pathological and clinical features of invasive lobular carcinoma (ILC) differ from those of invasive ductal carcinoma (IDC). Several studies have indicated that patients with ILC have a better prognosis th...

    Authors: Yayoi Adachi, Junko Ishiguro, Haruru Kotani, Tomoka Hisada, Mari Ichikawa, Naomi Gondo, Akiyo Yoshimura, Naoto Kondo, Masaya Hattori, Masataka Sawaki, Takashi Fujita, Toyone Kikumori, Yasushi Yatabe, Yasuhiro Kodera and Hiroji Iwata
    Citation: BMC Cancer 2016 16:248
  13. The proteasome is a validated anti-cancer target and various small-molecule inhibitors are currently in clinical development or on the market. However, adverse events and resistance associated with those prote...

    Authors: Jonghoon Park, Eok Park, Cheol-Kyu Jung, Seung-Wan Kang, Byung Gyu Kim, Youngjoo Jung, Tae Hun Kim, Ji-Young Lim, Sung-Eun Lee, Chang-Ki Min and Kwang-Ai Won
    Citation: BMC Cancer 2016 16:247
  14. ACFP is an anti-cancer fusion peptide derived from bovine milk protein. This study was to investigate the anti-cancer function and underlying mechanisms of ACFP in ovarian cancer.

    Authors: Juan Zhou, Mengjing Zhao, Yigui Tang, Jing Wang, Cai Wei, Fang Gu, Ting Lei, Zhiwu Chen and Yide Qin
    Citation: BMC Cancer 2016 16:246
  15. Eliminating cancer stem cells (CSCs) has been suggested for prevention of tumor recurrence and metastasis. Honokiol, an active compound of Magnolia officinalis, had been proposed to be a potential candidate drug ...

    Authors: Jhy-Shrian Huang, Chih-Jung Yao, Shuang-En Chuang, Chi-Tai Yeh, Liang-Ming Lee, Ruei-Ming Chen, Wan-Ju Chao, Jacqueline Whang-Peng and Gi-Ming Lai
    Citation: BMC Cancer 2016 16:245
  16. The prognostic value of rectal invasion is still unclear in stage IVA cervical cancer. The objective of this study is to evaluate patient outcome and prognostic factors in stage IVA cervical cancer treated wit...

    Authors: Masaru Wakatsuki, Shingo Kato, Hiroki Kiyohara, Tatsuya Ohno, Kumiko Karasawa, Tomoaki Tamaki, Ken Ando, Shintaro Shiba, Tadashi Kamada and Takashi Nakano
    Citation: BMC Cancer 2016 16:244
  17. The use of neoadjuvant radiation therapy and chemotherapy in the treatment of locally advanced rectal adenocarcinoma has been shown to reduce disease recurrence when combined with surgery and adjuvant chemothe...

    Authors: Matthew M. Florczynski, Michael S. Sanatani, Lauren Mai, Barbara Fisher, Dwight E. Moulin, Jeffrey Cao, Alexander V. Louie, Janet E. Pope and Eric Leung
    Citation: BMC Cancer 2016 16:243
  18. The diagnostic and prognostic significance of increased cathepsin B (CTSB) and cathepsin D (CTSD) concentration in the serum of cancer patients were evaluated for some tumor types. High expression of CTSD and ...

    Authors: Gongjun Tan, Qianxu Liu, Xiaowei Tang, Ting Kang, Yuejin Li, Jinping Lu, Xiaoming Zhao and Faqing Tang
    Citation: BMC Cancer 2016 16:241
  19. Tumor necrosis factor-alpha (TNF-α), a key player in cancer-related inflammation, was recently demonstrated to be involved in the lymphatic metastasis of gallbladder cancer (GBC). Vascular endothelial growth f...

    Authors: HaiJie Hong, Lei Jiang, YanFei Lin, CaiLong He, GuangWei Zhu, Qiang Du, XiaoQian Wang, FeiFei She and YanLing Chen
    Citation: BMC Cancer 2016 16:240
  20. Carbonic anhydrase IX (CA IX) is a tumor-associated, highly active, transmembrane carbonic anhydrase isoform regulated by hypoxia and implicated in pH control and adhesion-migration-invasion. CA IX ectodomain ...

    Authors: Ivana Vidlickova, Franck Dequiedt, Lenka Jelenska, Olga Sedlakova, Michal Pastorek, Stanislav Stuchlik, Jaromir Pastorek, Miriam Zatovicova and Silvia Pastorekova
    Citation: BMC Cancer 2016 16:239
  21. In previous investigation, we reported that stably knocking down cyclin-dependent kinase 4(CDK4) induced expression of let-7c, which further suppressed cell cycle transition and cell growth by modulating cell ...

    Authors: Zhen Liu, Chao Cheng, Xiaojun Luo, Qiong Xia, Yejie Zhang, Xiaobing Long, Qingping Jiang and Weiyi Fang
    Citation: BMC Cancer 2016 16:238

    The Retraction Note to this article has been published in BMC Cancer 2021 21:273

  22. Cancer services are inaccessible in many low-income countries, and few published examples describe oncology programs within the public sector. In 2011, the Rwanda Ministry of Health (RMOH) established Butaro C...

    Authors: Neo M. Tapela, Tharcisse Mpunga, Bethany Hedt-Gauthier, Molly Moore, Egide Mpanumusingo, Mary Jue Xu, Ignace Nzayisenga, Vedaste Hategekimana, Denis Gilbert Umuhizi, Lydia E. Pace, Jean Bosco Bigirimana, JingJing Wang, Caitlin Driscoll, Frank R. Uwizeye, Peter C. Drobac, Gedeon Ngoga…
    Citation: BMC Cancer 2016 16:237
  23. Epithelial-to-mesenchymal transition (EMT) has been associated with the acquisition of metastatic potential and the resistance of cancer cells to therapeutic treatments. MCF-7 breast cancer cells engineered to co...

    Authors: Roman Mezencev, Lilya V. Matyunina, Neda Jabbari and John F. McDonald
    Citation: BMC Cancer 2016 16:236
  24. In the analysis of survival data for cancer patients, the problem of competing risks is often ignored. Competing risks have been recognized as a special case of time-to-event analysis. The conventional techniq...

    Authors: Yen-Hou Chang, Wai-Hou Li, Yi Chang, Chia-Wen Peng, Ching-Hsuan Cheng, Wei-Pin Chang and Chi-Mu Chuang
    Citation: BMC Cancer 2016 16:235
  25. To improve adherence to physical activity (PA), behavioural support in the form of behavioural change counselling may be necessary. However, limited evidence of the effectiveness of home-based PA combined with...

    Authors: Ian M. Lahart, George S. Metsios, Alan M. Nevill, George D. Kitas and Amtul R. Carmichael
    Citation: BMC Cancer 2016 16:234
  26. Systemic chemotherapy combined with steroids used as prophylactic antiemetics have been reported to induce immunosuppression. Further, herpes simplex virus-1 (HSV-1) infection has been reported to occur in pat...

    Authors: Masaaki Saito, Hirokazu Kiyozaki, Tamotu Obitsu, Hirofumi Imoto, Yusuke Taniyama, Osamu Takata and Toshiki Rikiyama
    Citation: BMC Cancer 2016 16:233
  27. Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) is an autosomal dominant tumor susceptibility syndrome, and the disease-related gene has been identified as fumarate hydratase (fumarase, FH). HLRCC-asso...

    Authors: Takao Kamai, Hideyuki Abe, Kyoko Arai, Satoshi Murakami, Setsu Sakamoto, Yasushi Kaji and Ken-Ichiro Yoshida
    Citation: BMC Cancer 2016 16:232
  28. To compare the effects of resistance training versus passive physical therapy on bone turnover markers (BTM) in the metastatic bone during radiation therapy (RT) in patients with spinal bone metastases. Second...

    Authors: Harald Rief, Georg Omlor, Michael Akbar, Thomas Bruckner, Stefan Rieken, Robert Förster, Ingmar Schlampp, Thomas Welzel, Tilman Bostel, Heinz Jürgen Roth and Jürgen Debus
    Citation: BMC Cancer 2016 16:231
  29. Neoadjuvant endocrine therapy (NAE) has been employed to improve surgical outcomes for hormone receptor-positive breast cancers in postmenopausal women. Endocrine responsiveness is estimated by expressions of ...

    Authors: Takayuki Ueno, Shigehira Saji, Masahiro Sugimoto, Norikazu Masuda, Katsumasa Kuroi, Nobuaki Sato, Hiroyuki Takei, Yutaka Yamamoto, Shinji Ohno, Hiroko Yamashita, Kazufumi Hisamatsu, Kenjiro Aogi, Hiroji Iwata, Shigeru Imoto, Hironobu Sasano and Masakazu Toi
    Citation: BMC Cancer 2016 16:230
  30. 8000 cases of renal cancer are diagnosed each year in the UK, with a five-year survival rate of 50 %. Treatment options are limited; a potential therapeutic target is the Src family kinases (SFKs). SFKs have r...

    Authors: Antonia K. Roseweir, Tahir Qayyum, Zhi Lim, Rachel Hammond, Alasdair I. MacDonald, Sioban Fraser, Grenville M. Oades, Michael Aitchison, Robert J. Jones and Joanne Edwards
    Citation: BMC Cancer 2016 16:229
  31. The low survival rate of hepatocellular carcinoma (HCC) is partly attributable to its resistance to existing chemotherapeutic agents. Until now, there have been limited chemotherapeutic agents for liver cancer...

    Authors: Yan Li, Russell W. Farmer, Yingbin Yang and Robert C. G. Martin
    Citation: BMC Cancer 2016 16:228
  32. Genome-wide association studies (GWASs) have identified several single-nucleotide polymorphisms (SNPs) influencing the risk of thyroid cancer (TC). Most cancer predisposition genes identified through GWASs fun...

    Authors: Hauke Thomsen, Bowang Chen, Gisella Figlioli, Rossella Elisei, Cristina Romei, Monica Cipollini, Alfonso Cristaudo, Franco Bambi, Per Hoffmann, Stefan Herms, Stefano Landi, Kari Hemminki, Federica Gemignani and Asta Försti
    Citation: BMC Cancer 2016 16:227
  33. Post-transcriptional regulation by microRNAs is recognized as one of the major pathways for the control of cellular homeostasis. Less well understood is the transcriptional and epigenetic regulation of genes e...

    Authors: Erandi Ayala-Ortega, Rodrigo Arzate-Mejía, Rosario Pérez-Molina, Edgar González-Buendía, Karin Meier, Georgina Guerrero and Félix Recillas-Targa
    Citation: BMC Cancer 2016 16:226
  34. A large number of epigenetic alterations has been found to be implicated in the etiology of gastric cancer. We have studied the DNA methylation status of 27 500 gene promoter regions in 24 gastric adenocarcino...

    Authors: Lars Lohne Eftang, Jovana Klajic, Vessela N. Kristensen, Jörg Tost, Qin Ying Esbensen, Gustav Peter Blom, Ida Rashida Khan Bukholm and Geir Bukholm
    Citation: BMC Cancer 2016 16:225
  35. EGFR mutation-induced cell proliferation causes changes in tumor biology and tumor metabolism, which may reflect tumor marker concentration and 18F-FDG uptake on PET/CT. Direct aspirates of primary lung tumors...

    Authors: Arthur Cho, Jin Hur, Yong Wha Moon, Sae Rom Hong, Young Joo Suh, Yun Jung Kim, Dong Jin Im, Yoo Jin Hong, Hye-Jeong Lee, Young Jin Kim, Hyo Sup Shim, Jae Seok Lee, Joo-Hang Kim and Byoung Wook Choi
    Citation: BMC Cancer 2016 16:224
  36. Matrix metalloproteinases (MMPs) are crucially involved in the regulation of multiple stages of cancer progression. Elevated MMP levels have been associated with the development of metastases and poor prognosi...

    Authors: Pierre Kunz, Heiner Sähr, Burkhard Lehner, Christian Fischer, Elisabeth Seebach and Jörg Fellenberg
    Citation: BMC Cancer 2016 16:223
  37. Nephrotoxicity is the major side effect that limits the dose of cisplatin that can be safely administered, and it is a clinical problem in cancer patients who received cisplatin combination chemotherapy. Recen...

    Authors: Ko Sato, Satoshi Watanabe, Aya Ohtsubo, Satoshi Shoji, Daisuke Ishikawa, Tomohiro Tanaka, Koichiro Nozaki, Rie Kondo, Masaaki Okajima, Satoru Miura, Junta Tanaka, Takuro Sakagami, Toshiyuki Koya, Hiroshi Kagamu, Hirohisa Yoshizawa and Ichiei Narita
    Citation: BMC Cancer 2016 16:222
  38. High coverage and attendance is essential for cervical cancer screening success. We investigated whether the previous positive experiences on increasing screening attendance by self-sampling in Finland are sam...

    Authors: Liisa Karjalainen, Ahti Anttila, Pekka Nieminen, Tapio Luostarinen and Anni Virtanen
    Citation: BMC Cancer 2016 16:221
  39. Nanomedicine is a very promising field and nanomedical drugs have recently been used as therapeutic agents against cancer. In a previous study, we showed that Nanoceria (NCe), nanoparticles of cerium oxide, si...

    Authors: Miriana Hijaz, Soumen Das, Ismail Mert, Ankur Gupta, Zaid Al-Wahab, Calvin Tebbe, Sajad Dar, Jasdeep Chhina, Shailendra Giri, Adnan Munkarah, Sudipta Seal and Ramandeep Rattan
    Citation: BMC Cancer 2016 16:220
  40. Array CGH analysis of breast tumors has contributed to the identification of different genomic profiles in these tumors. Loss of DNA repair by BRCA1 functional deficiency in breast cancer has been proposed as ...

    Authors: Carolina Alvarez, Andrés Aravena, Teresa Tapia, Ester Rozenblum, Luisa Solís, Alejandro Corvalán, Mauricio Camus, Manuel Alvarez, David Munroe, Alejandro Maass and Pilar Carvallo
    Citation: BMC Cancer 2016 16:219
  41. Nasopharyngeal carcinoma (NPC) is prevalent in South East Asia and Southern China particularly, despite the reported 5-year survival ratio is relative higher than other deadly cancers such as liver, renal, pan...

    Authors: Man Niu, Dan Gao, Qiuyuan Wen, Pingpin Wei, Suming Pan, Cijun Shuai, Huiling Ma, Juanjuan Xiang, Zheng Li, Songqing Fan, Guiyuan Li and Shuping Peng
    Citation: BMC Cancer 2016 16:218
  42. To retrospectively assess the efficacy and safety of Vinflunine (VFL) under routine conditions and identify overall survival (OS) prognostic factors.

    Authors: Jacques Médioni, Mario Di Palma, Aline Guillot, Dominique Spaeth and Christine Théodore
    Citation: BMC Cancer 2016 16:217
  43. The role of remission status in limited disease (LD) small-cell lung cancer (SCLC) patients treated with definitive chemoradiotherapy (CRT) remains to be finally clarified.

    Authors: Farkhad Manapov, Maximilian Niyazi, Sabine Gerum, Olarn Roengvoraphoj, Chukwuka Eze, Minglun Li, Guido Hildebrandt, Rainer Fietkau, Gunther Klautke and Claus Belka
    Citation: BMC Cancer 2016 16:216
  44. Expression of the microRNA miR-21 has been found to be altered in almost all types of cancers and it has been classified as an oncogenic microRNA or oncomir. Due to the critical functions of its target protein...

    Authors: Oscar Peralta-Zaragoza, Jessica Deas, Angélica Meneses-Acosta, Faustino De la O-Gómez, Gloria Fernández-Tilapa, Claudia Gómez-Cerón, Odelia Benítez-Boijseauneau, Ana Burguete-García, Kirvis Torres-Poveda, Victor Hugo Bermúdez-Morales, Vicente Madrid-Marina, Mauricio Rodríguez-Dorantes, Alfredo Hidalgo-Miranda and Carlos Pérez-Plasencia
    Citation: BMC Cancer 2016 16:215
  45. Significant progress in treatment of metastatic castration resistant prostate cancer (mCRPC) has been made. Biomarkers to tailor therapy are scarce. To facilitate decision-making we evaluated dynamic changes o...

    Authors: Phillip Mikah, Laura-Maria Krabbe, Okyaz Eminaga, Edwin Herrmann, Philipp Papavassilis, Reemt Hinkelammert, Axel Semjonow, Andres-Jan Schrader and Martin Boegemann
    Citation: BMC Cancer 2016 16:214
  46. Changes in the number of alleles of a chromosome may have an impact upon gene expression. Loss of heterozygosity (LOH) indicates that one allele of a gene has been lost, and knowing the exact copy number of th...

    Authors: Peter Zauber, Stephen Marotta and Marlene Sabbath-Solitare
    Citation: BMC Cancer 2016 16:213
  47. To investigate whether genetic variants of the HBV receptor gene NTCP are associated with HBV infection in the Han Chinese population.

    Authors: Jingmin Yang, Yuan Yang, Mingying Xia, Lianghui Wang, Weiping Zhou, Yajun Yang, Yueming Jiang, Hongyang Wang, Ji Qian, Li Jin and Xiaofeng Wang
    Citation: BMC Cancer 2016 16:211

Featured videos

View featured videos from across the BMC-series journals